P4‐315: Evaluating amyloid‐beta processing using novel gamma‐secretase modulators in preclinical animal models
Kathleen M. Wood, Kelly R. Bales(Eli Lilly (United States)), Cathleen Gonzales, David Riddell(Eli Lilly (United States)), Martin Pettersson, Ashley Robshaw(Pfizer (United States)), Feng Pan(Hong Kong Polytechnic University), M. Marconi(Pfizer (United States)), Éva Hajós‐Korcsok(Pfizer (United States)), Nikolay Pozdnyakov(Pfizer (United States)), Dmitri Volfson(Pfizer (United States))
Cited by 1
Related Papers
ApoE Promotes the Proteolytic Degradation of Aβ
|Neuron|2008|869
Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model
|Nature Neuroscience|2002|858
Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
|Nature Genetics|1997|835
Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein
|Proceedings of the National Academy of Sciences|2005|659
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor
|Journal of Medicinal Chemistry|2012|460